Renk's Stock Hangs in the Balance Ahead of Key Updates

German defense supplier Renk reports record profit and backlog, yet shares slump 40% due to cash flow concerns and a high-stakes clash between bullish analysts and skeptical hedge funds.

The German defense supplier Renk finds itself at a curious crossroads. Despite reporting a near-doubling of net profit to €101 million for 2025 and a record order backlog of €6.7 billion, its shares languish nearly 40% below their all-time high. This stark disconnect between operational strength and market valuation has set the stage for a tense standoff between bullish analysts and skeptical hedge funds.

Investor unease is primarily fueled by cash flow. While sales climbed almost 20% to €1.37 billion and adjusted EBIT rose 22% to €230 million, the free cash flow of €67 million disappointed. The cash conversion rate slumped to 47.2%, well below the company's target of over 80%. This shortfall stems from delayed customer payments and postponed orders, meaning the money is booked but not yet in hand. Approximately €200 million in revenue has been pushed from 2025 into the first half of 2026.

Adding to the pressure are external headwinds. Pending export licenses for Israel are blocking potential revenues of up to €100 million. Furthermore, the company's heavy reliance on a few major defense programs—specifically the Leopard 2 tank and Puma infantry fighting vehicle—creates concentration risk. Any slowdown in these programs directly impacts quarterly results. The broader geopolitical climate, including a recent US-Iran weapons pause, has also weighed on the German defense sector.

This uncertainty has attracted significant short-selling activity. Prominent hedge fund AQR Capital Management recently increased its net short position to 2.30% of Renk's outstanding shares, betting the stock will fall. This bearish stance contrasts sharply with the view from major investment banks. JPMorgan reiterated an "Overweight" rating with a €75 price target on April 7, while DZ Bank sees a fair value of €65 per share. Goldman Sachs maintains a "Neutral" stance with a €70 target, with analyst Sam Burgess assessing the risk of genuine cuts to German defense spending as low.

The institutional investor base is similarly divided. Wellington Management recently crossed the 5% reporting threshold through substantial share purchases, demonstrating strong conviction. This creates a clear battle line between long-term believers and short-term doubters.

For the current year, Renk's management is targeting group revenue of over €1.5 billion. The projected adjusted EBIT is forecast between €255 million and €285 million, with the midpoint of this range sitting about 2% below the current analyst consensus. The company anticipates margin expansion as it scales industrial small-series production.

All eyes are now on two imminent events that could break the stalemate. On April 22, Renk's executive board will face analyst questions in a pre-close call. This will be followed by the official release of first-quarter figures on May 6. These updates will provide critical evidence on whether the company is overcoming its delivery delays and converting its massive backlog into tangible cash flow. A strong showing could squeeze the short sellers, while another disappointment may validate their pessimistic bets. The stock, which gained 1.2% to trade at €53.92 in recent activity, remains in technically oversold territory with an RSI of 29.3.